一种可预测早期卵巢癌术中包膜破裂风险的腹腔镜调整模型:腹腔镜卵巢癌溢出评分(LOChneSS研究)
该回顾性观察研究纳入2001年1月1日至2017年12月31日在意大利罗马Policlinico Universitario Agostino Gemelli IRCCS接受微创手术的151例FIGO IA-IC1期卵巢癌患者,分析术前和术中特征与肿瘤溢出的关系并开发评分系统。多因素分析显示肿瘤直径较大(p<.001)和卵巢窝腹膜粘连(p=.007)与术中肿瘤溢出独立相关并纳入评分。破裂组与未破裂组5年无病生存率分别为74.9%和94.4%(p=.011),5年总生存率分别为91.2%和97.9%(p=.089)。
要点
- 肿瘤直径较大和卵巢窝腹膜粘连是微创手术中肿瘤溢出的独立危险因素。
- 破裂组5年无病生存率74.9%低于未破裂组94.4%(p=.011)。
- 作者认为可考虑用腹腔镜预测模型术中调整手术方式以预防肿瘤溢出。
核心结论
- 某些术前和术中特征增加早期卵巢癌微创手术中肿瘤破裂的风险,腹腔镜包膜破裂预测模型可考虑用于术中调整手术方式以预防肿瘤溢出并避免影响患者无病生存。
研究设计与样本
- 回顾性观察研究,纳入2001年1月1日至2017年12月31日在意大利罗马Policlinico Universitario Agostino Gemelli IRCCS接受微创手术的151例FIGO IA-IC1期、任何组织学类型、年龄≥18岁的卵巢癌患者。
主要发现
- 既往盆腔手术在未破裂组更常见(46.0% vs 63.4%;p=.042)。
- 肿瘤直径较大(p<.001)、体重指数较高(p=.032)、超声特征(p=.029)以及大网膜粘连(14% vs 2.0%;p=.003)、子宫粘连(44% vs 6.9%;p<.001)、对侧卵巢粘连(8.0% vs 0%;p=.004)、卵巢窝粘连(64% vs 14.9%;p<.001)和直肠子宫陷凹腹膜粘连(32% vs 4.0%;p<.001)增加破裂率。
- 多因素分析中,肿瘤直径较大(p<.001)和卵巢窝腹膜粘连(p=.007)与术中肿瘤溢出独立相关并纳入评分计算。
- 破裂组与未破裂组5年无病生存率分别为74.9%和94.4%(p=.011),5年总生存率分别为91.2%和97.9%(p=.089)。
关键数值与推荐
- 评分计算纳入肿瘤直径较大(p<.001)和卵巢窝腹膜粘连(p=.007)两个独立相关因素。
临床怎么用
- 作者认为可考虑使用腹腔镜包膜破裂预测模型在术中调整手术方式以预防肿瘤溢出并避免影响患者无病生存。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To identify preoperative/intraoperative patient and tumor characteristics associated with an increased risk of tumor spillage during minimally invasive surgery (MIS) for early-stage ovarian cancer (OC). The secondary end point was to develop a score system able to estimate the risk of tumor rupture during MIS. DESIGN: Retrospective observational study. SETTING: Patients with International Federation of Gynecology and Obstetrics stage I OC. PATIENTS: Patients aged ≥18 years old, with International Federation of Gynecology and Obstetrics stage IA to IC1 OC of any histology. INTERVENTIONS: Preoperative and intraoperative characteristics of patients treated with MIS for early-stage OC at Policlinico Universitario Agostino Gemelli, IRCCS in Rome, Italy, from January 1, 2001, to December 31, 2017, were collected. MEASUREMENTS AND MAIN RESULTS: A total of 151 patients were included. Previous pelvic surgery was more represented in patients with nonruptured tumors (46.0% vs 63.4%; p = .042). In addition, a larger tumor diameter (p <.001), a higher body mass index (p = .032), ultrasound characteristics (p = .029), and adhesions to large bowel (14% vs 2.0%; p = .003), uterus (44% vs 6.9%; p <.001), contralateral ovary (8.0% vs 0%; p = .004), ovarian fossa (64% vs 14.9%; p <.001), and pouch of Douglas peritoneum (32% vs 4.0%; p <.001) increased rupture rate. At multivariate analysis, a larger tumor diameter (p <.001) and adhesions to ovarian fossa peritoneum (p = .007) were independently associated with intraoperative cancer spillage and included in the score calculation. A disease-free survival (DFS) difference between the rupture group and the no-rupture group was detected (5-year DFS, 74.9% vs 94.4%; p = .011), with superimposable overall survival (5-year overall survival, 91.2% vs 97.9%; p = .089). CONCLUSION: Some preoperative/intraoperative characteristics increase the risk of tumor rupture during MIS for early-stage OC. A laparoscopic predictive model of capsule disruption could be considered to intraoperatively tailor surgical approach to prevent tumor spillage and avoid affecting patient's DFS.
引用
- Ghirardi V, De Felice F, Rosati A, et al. A Laparoscopic Adjusted Model Able to Predict the Risk of Intraoperative Capsule Rupture in Early-stage Ovarian Cancer: Laparoscopic Ovarian Cancer Spillage Score (LOChneSS Study). J Minim Invasive Gynecol. 2022. PMID: 35500747. doi:10.1016/j.jmig.2022.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。